Efficacy of Er: YSGG Laser in Treatment of Peri-implantitis

November 17, 2023 updated by: alaa, Ain Shams University

Efficacy of Er: YSGG Laser on Oral Biofilm Removal From Implant Surface and Its Biological Response to Periodontal Tissues in Treatment of Peri-implantitis (An Ex Vivo Study)

This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective.

To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.

Study Overview

Status

Completed

Conditions

Detailed Description

This study will be carried out to evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in various peri-implant defect morphology in the treatment of peri-implantitis as a primary objective.

To assess the morphological changes and the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through Profilometer analysis and cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs) respectively as secondary objectives.

The study was designed as an Ex Vivo study. Four periodontally and systemically healthy volunteers of both gender are included in this study for the formation of in vivo plaque biofilm. Each volunteer will wear a hard resin splint carrying six rough (machined implant; 3.3mm diameter, 8mm length) for 4 days to accumulate dental plaque naturally on the titanium surfaces of the implants.

Therefore, 24 implants will be assessed for Er: YSGG laser therapy in different bone defect simulators.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11411
        • Ain Shams Dental School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Sex: female or male.
  • Age: 25 - 55 years.
  • Medically controlled according to medical coding of review of systems (ROS)

Exclusion Criteria:

  • Tobacco smoking for at least 6 months before the study enrollment

    • Participants with ill-fitting restorations in both upper first molars that affect the stability of the stent.
    • Participants not following oral hygiene instructions.
    • Participants on dental treatment during the study period.
    • Participants with a history of drug administration
    • Vulnerable group.
    • Participants with long-term mouthwash administration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: non tested comparative group
two sealed new implants as a control
new sealed implant without any surface treatment
Experimental: Er: YSGG laser tested group
24 infected implants divided into four subgroups that will be decontaminated by Er: YSGG laser in various peri-implant defects
Er: YSGG laser decontamination of infected implant surfaces to simulate peri-implantitis therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visual inspection of the oral biofilm removal efficacy by image analysis software (Adobe Photoshop
Time Frame: 2 weeks

evaluate the efficacy of Er: YSGG laser on oral biofilm removal from implant surface in

various peri-implant defect morphology

2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Profilometer analysis of surface roughness changes
Time Frame: 1 month
assess the morphological changes of implant surface after Er: YSGG laser therapy through Profilometer analysis
1 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
biocompatibility test of the surface
Time Frame: 2 months
assess the biological response (biocompatibility) of implant surface after Er: YSGG laser therapy through cell culture process to detect attachment, differentiation, and mineralization of Isolated rat Bone Marrow Mesenchymal stem cells (rBMMSCs)
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 10, 2023

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

November 15, 2023

Study Registration Dates

First Submitted

October 1, 2021

First Submitted That Met QC Criteria

November 16, 2021

First Posted (Actual)

November 30, 2021

Study Record Updates

Last Update Posted (Estimated)

November 21, 2023

Last Update Submitted That Met QC Criteria

November 17, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • FDASU-REC ID210314

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peri-Implantitis

Clinical Trials on no therapy

3
Subscribe